Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

FDA Approves H Lundbeck A/S's Antidepressant Brintellix-Reuters

Monday, 30 Sep 2013 06:24pm EDT 

Reuters reported that The U.S. Food and Drug Administration approved H Lundbeck A/S's antidepressant Brintellix to treat adults with depressive disorder. The drug, which Lundbeck will co-market with Japanese partner Takeda Pharmaceutical Co Ltd will be available in four doses.